Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VKTX compared with ABVX: revenue, margins and what each company keeps, and the suppliers and customers both name
VKTX
Viking Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ABVX
Abivax S.A.
Change
Mkt cap
Revenue
Revenue
vs
Compare
VKTX
Viking Therapeutics, Inc.
vs
ABVX
Abivax S.A.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
VKTX
2 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±6.5%
▲
+5.91%
×0.91
Q2 FY26
—
▼
−0.96%
—
ABVX
No earnings history for ABVX.
= implied
VKTX realized, solid
ABVX realized, hatched
One scale, both sides: full bar = 7%
× = |realized| ÷ implied
Source: market data
VKTX
Viking Therapeutics, Inc.
Change
26.86
▲
+4.15%
· post 26.86
Mkt cap
$3.4B
ABVX
Abivax S.A.
Change
86.43
▲
+2.68%
· post 86.44
Closed
Nov 6 '26
Mkt cap
$6.0B
vs
Compare
Closed
Nov 6 '26
VKTX
Viking Therapeutics, Inc.
vs
ABVX
Abivax S.A.
26.86
▲
+4.15%
post 26.86
Price
86.43
▲
+2.68%
post 86.44
$3.4B
Mkt cap
$6.0B
Change
Change
VKTX
26.86
▲
+4.15%
vs
ABVX
86.43
▲
+2.68%
Closed
Nov 6 '26